Brain-Zapping ultrasound tested with drug in fight against recurrent cancer
Disease control
Not yet recruiting
This is a small, early-stage study to see if a combination treatment is safe for people with a specific type of recurrent brain cancer (glioblastoma). Doctors will use a focused ultrasound device to target the tumor area along with an immunotherapy drug called pembrolizumab. The …
Phase: PHASE1 • Sponsor: Jennifer Leddon • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC